Zenas BioPharma, Inc. Current Liabilities
Zenas BioPharma, Inc. (ZBIO) had Current Liabilities of $65.82 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $65.82M.
- 2026-03-31: Liabilities, Current $61.16M.
- 2025-12-31: Liabilities, Current $62.65M.
- 2025-09-30: Liabilities, Current $52.42M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $65.82M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $61.16M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $62.65M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $52.42M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $53.24M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $49.13M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $57.29M 10-K · filed 2026-03-16 |
| 2024-09-30 | $44.00M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $23.26M 10-K · filed 2025-03-11 |